Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials

Vitamin K to prevent fractures in older women: systematic review and economic evaluation

(2014) M Stevenson et al.   HEALTH TECHNOLOGY ASSESSMENT

Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women

(2013) M. H. J. Knapen et al.   OSTEOPOROSIS INTERNATIONAL

Changes in Parameters of Bone Metabolism in Postmenopausal Women Following a 12-Month Intervention Period Using Dairy Products Enriched with Calcium, Vitamin D, and Phylloquinone (Vitamin K1) or Menaquinone-7 (Vitamin K2): The Postmenopausal Health Study II

(2012) Spyridon Kanellakis et al.   CALCIFIED TISSUE INTERNATIONAL

Prospective evaluation of Vitamin K2, Raloxifene and their co-administration in osteoporotic rats

(2011) A.G. Tasci et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Possible site-specific effect of an intervention combining nutrition and lifestyle counselling with consumption of fortified dairy products on bone mass: the Postmenopausal Health Study II

(2011) George Moschonis et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials

(2011) Yanfu Fang et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Vitamin K Supplement Along with Vitamin D and Calcium Reduced Serum Concentration of Undercarboxylated Osteocalcin While Increasing Bone Mineral Density in Korean Postmenopausal Women over Sixty-Years-Old

(2011) Sang Hyeon Je et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Relationships between undercarboxylated osteocalcin and vitamin K intakes, bone turnover, and bone mineral density in healthy women

(2010) Mika Yamauchi et al.   CLINICAL NUTRITION

Efficacy of Menatetrenone (Vitamin K2) against Non-Vertebral and Hip Fractures in Patients with Neurological Diseases

(2009) Jun Iwamoto et al.   CLINICAL DRUG INVESTIGATION

Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study

(2009) Masataka Shiraki et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis

(2009) P. J. Meunier et al.   OSTEOPOROSIS INTERNATIONAL

Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial

(2009) N. Emaus et al.   OSTEOPOROSIS INTERNATIONAL

2009 Updated Method Guidelines for Systematic Reviews in the Cochrane Back Review Group

(2009) Andrea D. Furlan et al.   SPINE

Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women

(2008) Makoto Hirao et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules

(2008) Tetsuo Inoue et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Vitamin K Treatment Reduces Undercarboxylated Osteocalcin but Does Not Alter Bone Turnover, Density, or Geometry in Healthy Postmenopausal North American Women

(2008) Neil Binkley et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in Osteoporosis

(2006) Masataka Shiraki et al.   JOURNAL OF BONE AND MINERAL RESEARCH